These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 31152315

  • 1. MiR-873-5p suppresses cell proliferation and epithelial-mesenchymal transition via directly targeting Jumonji domain-containing protein 8 through the NF-κB pathway in colorectal cancer.
    Wang L, Jiang F, Ma F, Zhang B.
    J Cell Commun Signal; 2019 Dec; 13(4):549-560. PubMed ID: 31152315
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-1224-5p Inhibits Metastasis and Epithelial-Mesenchymal Transition in Colorectal Cancer by Targeting SP1-Mediated NF-κB Signaling Pathways.
    Li J, Peng W, Yang P, Chen R, Gu Q, Qian W, Ji D, Wang Q, Zhang Z, Tang J, Sun Y.
    Front Oncol; 2020 Dec; 10():294. PubMed ID: 32231999
    [Abstract] [Full Text] [Related]

  • 3. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma.
    Mei LL, Wang WJ, Qiu YT, Xie XF, Bai J, Shi ZZ.
    Int J Mol Sci; 2017 Aug 23; 18(9):. PubMed ID: 28832500
    [Abstract] [Full Text] [Related]

  • 4. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα.
    Xin H, Wang C, Liu Z.
    BMC Cancer; 2019 Jan 08; 19(1):30. PubMed ID: 30621631
    [Abstract] [Full Text] [Related]

  • 5. Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.
    Sun M, Song H, Wang S, Zhang C, Zheng L, Chen F, Shi D, Chen Y, Yang C, Xiang Z, Liu Q, Wei C, Xiong B.
    J Hematol Oncol; 2017 Mar 29; 10(1):79. PubMed ID: 28356122
    [Abstract] [Full Text] [Related]

  • 6. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C, Zhang L, Sun Y, Li X, Zhan L, Lou Y, Wang Y, Liu L, Zhang Y.
    Biomed Pharmacother; 2018 May 29; 101():945-952. PubMed ID: 29635904
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer.
    Yan S, Liu G, Jin C, Wang Z, Duan Q, Xu J, Xu D.
    J Cell Physiol; 2018 Sep 29; 233(9):6660-6668. PubMed ID: 29206292
    [Abstract] [Full Text] [Related]

  • 8. miR-145-5p suppresses proliferation, metastasis and EMT of colorectal cancer by targeting CDCA3.
    Chen Q, Zhou L, Ye X, Tao M, Wu J.
    Pathol Res Pract; 2020 Apr 29; 216(4):152872. PubMed ID: 32107086
    [Abstract] [Full Text] [Related]

  • 9. miR-217-5p suppresses epithelial-mesenchymal transition and the NF-κB signaling pathway in breast cancer via targeting of metadherin.
    Yang L, Liu S, Yang L, Xu B, Wang M, Kong X, Song Z.
    Oncol Lett; 2022 May 29; 23(5):162. PubMed ID: 35399330
    [Abstract] [Full Text] [Related]

  • 10. MiR-410-3p activates the NF-κB pathway by targeting ZCCHC10 to promote migration, invasion and EMT of colorectal cancer.
    Ma ZH, Shi PD, Wan BS.
    Cytokine; 2021 Apr 29; 140():155433. PubMed ID: 33517196
    [Abstract] [Full Text] [Related]

  • 11. LncRNA XIST facilitates proliferation and epithelial-mesenchymal transition of colorectal cancer cells through targeting miR-486-5p and promoting neuropilin-2.
    Liu A, Liu L, Lu H.
    J Cell Physiol; 2019 Aug 29; 234(8):13747-13761. PubMed ID: 30656681
    [Abstract] [Full Text] [Related]

  • 12. Long Non-coding RNA Zinc Finger Antisense 1 (ZFAS1) Regulates Proliferation, Migration, Invasion, and Apoptosis by Targeting MiR-7-5p in Colorectal Cancer.
    Mo D, Liu W, Li Y, Cui W.
    Med Sci Monit; 2019 Jul 11; 25():5150-5158. PubMed ID: 31295229
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Colorectal cancer cell-derived exosomal miRNA-372-5p induces immune escape from colorectal cancer via PTEN/AKT/NF-κB/PD-L1 pathway.
    Wu Y, Xiao Y, Ding Y, Ran R, Wei K, Tao S, Mao H, Wang J, Pang S, Shi J, Zhu C, Wan W, Yang Q, Chen C.
    Int Immunopharmacol; 2024 Dec 25; 143(Pt 1):113261. PubMed ID: 39353381
    [Abstract] [Full Text] [Related]

  • 16. MiR-9-5p suppresses cell metastasis and epithelial-mesenchymal transition through targeting FOXP2 and predicts prognosis of colorectal carcinoma.
    Wang WX, Yu HL, Liu X.
    Eur Rev Med Pharmacol Sci; 2019 Aug 25; 23(15):6467-6477. PubMed ID: 31378886
    [Abstract] [Full Text] [Related]

  • 17. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
    Niu Y, Zhang J, Tong Y, Li J, Liu B.
    Int J Biochem Cell Biol; 2019 Dec 25; 117():105641. PubMed ID: 31693935
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. miR-125a-5p inhibits colorectal cancer cell epithelial-mesenchymal transition, invasion and migration by targeting TAZ.
    Tang L, Zhou L, Wu S, Shi X, Jiang G, Niu S, Ding D.
    Onco Targets Ther; 2019 Dec 25; 12():3481-3489. PubMed ID: 31190857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.